Horm Metab Res 2013; 45(07): 507-512
DOI: 10.1055/s-0033-1334944
Original Basic
© Georg Thieme Verlag KG Stuttgart · New York

N-3 Polyunsaturated Fatty Acids Supplementation Does not Affect Changes of Lipid Metabolism Induced in Rats by Altered Thyroid Status

H. Rauchová
1   Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
,
M. Vokurková
1   Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
,
S. Pavelka
1   Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
,
M. Behuliak
1   Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
,
N. Tribulová
2   Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic
,
T. Soukup
1   Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
› Author Affiliations
Further Information

Publication History

received 01 October 2012

accepted 04 February 2013

Publication Date:
18 March 2013 (online)

Abstract

Epidemiological studies have demonstrated that n-3 polyunsaturated fatty acid (PUFA) consumption is associated with a reduced risk of atherosclerosis and hyperlipidemia. It is well known that lipid metabolism is also influenced by thyroid hormones. The aim of our study was to test whether n-3 PUFA supplementation (200 mg/kg of body weight/day for 6 weeks given intragastrically) would affect lipid metabolism in Lewis male rats with altered thyroid status. Euthyroid, hypothyroid, and hyperthyroid status of experimental groups was well defined by plasma levels of triiodothyronine, the activity of liver mitochondrial glycerol-3-phosphate dehydrogenase, and by relative heart weight. Fasting blood glucose levels were significantly higher in the hyperthyroid compared to the euthyroid and hypothyroid rats (5.0±0.2 vs. 3.7±0.4 and 4.4±0.2 mmol/l, respectively). In hyperthyroid animals, the concentration of plasma postprandial triglycerides was also increased compared to euthyroid and hypothyroid rats (0.9±0.1 vs. 0.5±0.1 and 0.4±0.1 mmol/l, respectively). On the other hand, hypothyroidism compared to euthyroid and hyperthyroid status was associated with elevated plasma levels of total cholesterol (2.6±0.2 vs. 1.5±0.1 and 1.6±0.1 mmol/l, respectively), LDL cholesterol (0.9±0.1 vs. 0.4±0.1 and 0.2±0.1 mmol/l, respectively) as well as HDL cholesterol (1.6±0.1 vs. 1.0±0.1 and 1.3±0.1 mmol/l, respectively). Supplementation of n-3 PUFA in the present study did not significantly modify either relative heart weight or glucose and lipid levels in any thyroid status.

 
  • References

  • 1 Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001; 81: 1097-1142
  • 2 Oetting A, Yen PM. New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab 2007; 21: 193-208
  • 3 Muls E, Rosseneu M, Blaton V, Lesaffre E, Lamberigts G, de Moor P. Serum lipids and apolipoproteins A-I, A-II and B in primary hypothyroidism before and during treatment. Eur J Clin Invest 1984; 14: 12-15
  • 4 Santi A, Duarte MM, Moresco RN, Menezes C, Bagatini MD, Schetinger MR, Loro VL. Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clin Chem Lab Med 2010; 48: 1635-1639
  • 5 Muls E, Blaton V, Rosseneu M, Lesaffre E, Lamberigts G, De Moor P. Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment. J Clin Endocrinol Metab 1982; 55: 459-464
  • 6 Taylor AH, Stephan ZF, Steele RE, Wong NCW. Beneficial effect of a novel thyromimetic on lipoprotein metabolism. Mol Pharmacol 1997; 52: 542-547
  • 7 Erion MD, Cable EE, Ito BR, Jiang H, Fujitaki JM, Finn PD, Zhang BH, Hou J, Boyer SH, van Poelje PD, Linemeyer DL. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. Proc Natl Acad Sci USA 2007; 104: 15490-15495
  • 8 Danzi S, Klein I. Cardiac specific effects of thyroid hormone analogues. Horm Metab Res 2011; 43: 737-742
  • 9 Harris WS. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997; 65 (Suppl) 1645S-1654S
  • 10 Harris WS. n-3 Fatty acids and serum lipoproteins: animal studies. Am J Clin Nutr 1997; 65 (Suppl) 1611S-1616S
  • 11 Bays HE, Tighe AP, Sadovsky R, Davidson MH. Prescription omega-3 fatty acids and their lipid effects: physiological mechanisms of action and clinical implications. Expert Rev Cardiovasc Ther 2008; 6: 391-409
  • 12 Davidson MH, Kling D, Maki KC. Novel developments in omega-3 fatty acids-based strategies. Curr Opin Lipidol 2011; 22: 437-444
  • 13 Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 2010; 21: 781-792
  • 14 Bordoni A, Di Nunzio M, Danesi F, Biagi PL. Polyunsaturated fatty acids: From diet to binding to PPARs and other nuclear receptors. Genes Nutr 2006; 1: 95-106
  • 15 Jump DB. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 2008; 19: 242-247
  • 16 Sugiyama E, Ishikawa Y, Li Y, Kagai T, Nobayashi M, Tanaka N, Kamijo Y, Yokoyama S, Hara A, Aoyama T. Eicosapentaenoic acid lowers plasma and liver cholesterol levels in the presence of peroxisome proliferators-activated receptor alpha. Life Sci 2008; 83: 19-28
  • 17 Liu YY, Brent GA. Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation. Trends Endocrinol Metab 2010; 21: 166-173
  • 18 Souza LL, Cordeiro A, Oliveira LS, de Paula GS, Faustino LC, Ortiga-Carvalho TM, Oliveira KJ, Pazos-Moura CC. Thyroid hormone contributes to the hypolipidemic effect of polyunsaturated fatty acids from fish oil: in vivo evidence for cross talking mechanisms. J Endocrinol 2011; 211: 65-72
  • 19 Mitasiková M, Šmídová S, Macsaliová A, Knezl V, Dlugošová K, Okruhlicová L, Weismann P, Tribulová N. Aged male and female spontaneously hypertensive rats benefit from n-3 polyunsaturated fatty acids supplementation. Physiol Res 2008; 57 (Suppl. 02) S39-S48
  • 20 Radošinská J, Bačová B, Bernatová I, Navarová J, Zhukovská A, Shysh A, Okruhlicová L, Tribulová N. Myocardial NOS activity and connexin-43 expression in untreated and omega-3 fatty acids-treated spontaneously hypertensive and hereditary hypertriglyceridemic rats. Mol Cell Biochem 2011; 347: 163-173
  • 21 Rauchová H, Zachařová G, Soukup T. Influence of chronically altered thyroid status on the activity of liver mitochondrial glycerol-3-phosphate dehydrogenase in female inbred Lewis rats. Horm Metab Res 2004; 36: 286-290
  • 22 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
  • 23 Rauchová H, Mráček T, Novák P, Vokurková M, Soukup T. Glycerol-3-phosphate dehydrogenase expression and oxygen consumption in liver mitochondria of female and male rats with chronic alteration of thyroid status. Horm Metab Res 2011; 43: 43-47
  • 24 Souza LL, Nunes MO, Paula GSM, Cordeiro A, Penha-Pinto V, Neto JFN, Oliveira KJ, do Carmo MGT, Pazos-Moura CC. Effects of dietary fish oil on thyroid hormone signaling in the liver. J Nutr Biochem 2010; 21: 935-940
  • 25 Deshpande N, Hulbert AJ. Dietary omega 6 fatty acids and the effects of hyperthyroidism in mice. J Endocrinol 1995; 144: 431-439
  • 26 Weitzel JM, Kutz S, Radtke C, Grott S, Seitz HJ. Hormonal regulation of multiple promoters of the rat mitochondrial glycerol-3-phosphate dehydrogenase gene: identification of a complex hormone-response element in the ubiquitous promoter B. Eur J Biochem 2001; 268: 4095-4103
  • 27 Novák P, Zachařová G, Soukup T. Individual, age and sex differences in fiber type composition of slow and fast muscles of adult Lewis strain rats. Comparison with other rat strains. Physiol Res 2010; 59: 783-801
  • 28 Keyes WC, Heimberg N. Influence of thyroid status on lipid metabolism in the perfused rat liver. J Clin Invest 1979; 64: 182-190
  • 29 Maćkowiak P, Ginalska E, Novak-Strojec E, Szkudelski T. The influence of hypo- and hyperthyreosis on insulin receptors and metabolism. Arch Physiol Biochem 1999; 107: 273-279
  • 30 López-Torres M, Romero M, Barja G. Effect of thyroid hormones on mitochondrial oxygen free radical production and DNA oxidative damage in the rat heart. Mol Cell Endocrinol 2000; 168: 127-134
  • 31 Soukup T, Zachařová G, Smerdu V, Jirmanová I. Body, heart, thyroid gland and skeletal muscle weight changes in rats with altered thyroid status. Physiol Res 2001; 50: 619-626
  • 32 Venditti P, De Rosa R, Di Meo S. Effect of thyroid state on susceptibility to oxidants and swelling of mitochondria from rat tissues. Free Radic Biol Med 2003; 35: 485-494
  • 33 Kruger MJ, Engelbrecht AM, Esterhuyse J, Du Toit EF, Van Royen J. Dietary red palm oil reduced ischemia-reperfusion injury in rats fed a hypercholesterolaemic diet. Br J Nutr 2007; 97: 653-660
  • 34 Bester DJ, Kupa K, Csont T, Szuck G, Csonka C, Esterhuyse AJ, Ferdinandy P, Van Royen J. Dietary red palm oil supplementation reduces myocardial infarct size in an isolated perfused rat heart model. Lipids Health Disease 2010; 9: 64
  • 35 Potenza M, Via MA, Yanagisawa RT. Excess thyroid hormone and carbohydrate metabolism. Endocr Pract 2009; 15: 254-262
  • 36 Raederstorff D, Meier CA, Moser U, Walter P. Hypothyroidism and tyroxin substitution affect the n-3 fatty acid composition of rat liver mitochondria. Lipids 1991; 26: 781-787
  • 37 Roche HM, Gibney MJ. Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am J Clin Nutr 2000; 71 (Suppl) 223S-227S
  • 38 Zhang Z, Wang H, Jiao R, Peng C, Wong YM, Yeung VS, Huang Y, Chen ZY. Choosing hamster but not rats as a model for studying plasma cholesterol-lowering activity of functional foods. Mol Nutr Food Res 2009; 53: 921-930
  • 39 Ikeda I, Imasato Y, Nagao H, Sasaki E, Sugano M, Imaizumi K, Yazawa K. Lymphatic transport of eicosapentaenoic and docosahexaenoic acids as triglyceride, ethyl ester and free acid, and their effect on cholesterol transport in rats. Life Sci 1993; 52: 1371-1379